Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,663 total articles
UnitedHealth (UNH) reported a crisp operational beat in Q3 driven by improving Optum margins and AI-enabled workflow gains. With Q3 revenue of $113 billion, raised 2026 EPS guidance to at least $20.50 and Optum margins expanding to 5.6%, the risk/reward supports a long trade. My plan: enter at market near $419.29, stop $385.00, target $480.00 on a …
McEwen (MUX) is trading near its 52-week low but has been actively de-risking its balance sheet and advancing high-return projects. With roughly $980M market cap, a sizeable short position and several near-term corporate/cash catalysts, there is a tactical opportunity to buy a controlled position. This idea is a mid-term swing trade that banks on c…
Tencent is executing a strategic pivot from a dominant social-and-entertainment franchise into an AI-first platform company. This trade idea proposes a long position sized for a mid-to-long-term runway to capture re-rating from AI monetization and cloud expansion while controlling downside with a defined stop.
Papa John's has been punished this year as transformation delays, market-share pressure and a suspended dividend forced a reset. The share price now trades near a 52-week low with an EV/EBITDA of ~7.7 and free cash flow generation, creating a risk-reward setup for a mid-term swing trade. This idea is a rated upgrade to a tactical long with clear en…
Shares of Sandisk have corrected hard from the highs, but the sell-off appears sentiment-driven rather than a fundamental collapse. Strong Q4 metrics, massive free cash flow and 84.6% gross margins in recent quarters combined with a reasonable P/E make a disciplined long entry attractive. This trade idea lays out an entry at $1378.22, a stop at $11…
ASGI's share price has been under pressure following a rights offering and short-term volatility. With the distribution intact at $0.22/month (implying a ~13.6% annualized cash yield at current levels), technicals stabilizing near short-term moving averages, and the overhang largely priced in, we see a tactical long entry for investors who want inc…
Parabilis has pivoted into a foundation built around rare-disease assets while effectively relinquishing a capital-intensive oncology pipeline. That repositioning creates a clear, fundable pathway to clinical value capture and near-term binary events. Risk is high, but asymmetric upside and a clear set of catalysts make a disciplined long trade att…
Silicon Motion (SIMO) is trading below its short-term moving averages on oversold momentum even as revenue and EPS expectations have leaped for 2026. With MonTitan and new UFS/U.3 controller ramps contributing to diversification beyond smartphone eMMC/UFS, SIMO offers an actionable mid-term long with defined risk controls. Entry at $215.49, stop $1…
Palantir is trading near record highs on strong growth, but Wall Street chatter centers on future margin compression. The numbers say otherwise: Palantir's adjusted profitability and free cash flow are already industry-leading. This trade idea takes a constructive stance with a clear entry, stop and target over a 180-trading-day horizon.
Universal Health Services (UHS) is trading at single-digit earnings multiples, generating meaningful free cash flow and actively expanding its behavioral health footprint (Talkspace deal). With heavy short interest and constructive technicals, a orderly re-rating to mid-teens P/E would support a move to our $434.30 target. We present a long-term tr…
Lululemon has been hit hard by guidance cuts, slowing comps and a headline-driven sell-off, but the market now prices the company at roughly $11.5B market cap with EV/EBITDA below 4 and trailing P/E near 8. This trade targets a recovery in sentiment and margin stabilization over the next 180 trading days while keeping a tight stop beneath proven su…
Dorian LPG reported sturdy operational results, but recent price action appears to factor in an extended cycle premium. The balance sheet and cash generation give the company resilience, yet valuation looks compressed for downside protection. We propose a disciplined short trade for traders who want to exploit a likely mean reversion over the next …
IQVIA is showing renewed momentum in Research & Development Solutions with bookings up ~19% and a near-term backlog that underpins revenue visibility. The shares are trading at ~32-33x earnings with EV/EBITDA ~16x, which demands continued execution on conversion, margin expansion and cash generation. This trade idea is a conditional long: enter now…
Freshpet (FRPT) is a buy for a mid-term trade. The stock is trading around $65.48 with a market cap near $3.15B, reasonable leverage and healthy cash generation. Recent conference disclosures were constructive and, combined with consensus estimates that already bake in EPS pressure, leave room for a beat on the November 4 Q3 release. Technicals and…
Coupang is trading near a multi-month low despite owning one of the fastest, densest logistics networks in Asia. The combination of a defensible last-mile footprint, improving momentum in technical indicators, and a valuation that prices in continued weakness creates a tactical mid-term long opportunity. Entry $14.30, stop $12.90, target $18.50 ove…
Mitsubishi UFJ Financial Group (MUFG) is a pragmatic buy here. With a market cap near $257.5B, a PE of ~14x and a 2.73% yield, MUFG looks fairly priced relative to the earnings upside tied to higher-return segments - Global CIB, Markets and Asset Management - in a higher-for-longer rate environment. Technicals show near-term weakness, but a discipl…
American Public Education (APEI) is a $905M education-services company that can convert incremental revenue into disproportionately higher profits as fixed costs are leveraged. With trailing EPS of $2.50, free cash flow of $70.1M and EV/EBITDA near 10.0, we see room for multiple expansion if growth and margin tailwinds continue. This trade targets …
Super Micro Computer (SMCI) is trading well below its 52-week high after a pullback, but fundamental momentum - big expected revenue and EPS beats, improving margins and a strong balance-sheet cushion - argues for a mid-term long. The stock's valuation (market cap ~$21.2B, EV/sales ~0.57, P/E ~9.6) looks inexpensive relative to the growth on paper.…
Farmers National Banc (FMNB) trades at an attractive price-to-book and pays a ~4.5% yield. Recent M&A expands its Ohio footprint and recent fundamentals show steady profitability, but pockets of CRE stress and M&A legal scrutiny keep risk elevated. Here’s a concrete trade plan to capture upside into improved fundamentals while limiting downside.
PBF Energy (PBF) combines cyclical upside from stronger diesel margins and refinery restarts with a balance sheet that supports cash returns and investments. At $81.65 today and trading near an attractive EV/EBITDA of 4.3x, PBF looks like the best way to play the current refining rally. This article lays out a concrete entry at $81.65, a stop at $7…
Amazon's core fundamentals remain intact despite headline volatility. The market is overselling cyclicality in retail and missing the structural margin leverage in AWS and advertising. This trade idea targets a disciplined long with defined entry, stop, and objective tied to catalyst flow over the next 180 trading days.
DLR trades at $173.78 with a $64.5B market cap and a stretched multiple, but recent evidence - from APAC demand surveys to new capacity in Osaka and a power-constrained market - argues for prioritizing contracted leases over speculative AI re-rates. This trade idea lays out a mid-term long with entry, stop, targets and the risks that could derail t…
Western Alliance ($WAL) looks like an attractive swing trade today. The stock trades at roughly $75.45 with a market cap near $8.2B, a P/E around 8x and P/B near 1x. Recent Q3 results showed revenue of $1.02B and EPS of $2.45, with net interest margin improving to 3.6% even as the efficiency ratio widened. Credit noise from an isolated borrower law…
Braveheart Bio's BHB-1839 looks like a differentiated small-molecule myosin inhibitor for non-obstructive hypertrophic cardiomyopathy (HCM). With a market cap of $1.73B, insider buying at the IPO, and early Phase 2 data that support a favorable therapeutic window, there is a tactical long opportunity with defined risk. Entry $19.24, target $32.00, …
We upgrade Texas Pacific Land (TPL) to a bullish rating. The company is a rare combination of high-return legacy royalties and fast-growing infrastructure optionality tied to AI data center buildout and water services in the Permian. Valuation is rich, but cash generation ($526.7M free cash flow) and strong ROE (32%) provide a defensive underpin. T…
